We manufacture a range of APIs and Intermediates.
| Product | CAS No. | Used In |
|---|---|---|
| Isometamedium Chloride | 6798-24-9 | Antitrypanosomal Agent |
| Homidium Bromide | 1239-45-8 | Antiprotozoal (Trypanosoma) |
| Homidium Chloride Ex Alcohol | 602-52-8 | Antiprotozoal (Trypanosoma) |
| Buparvaquone | 88246-33-9 | Antiprotozoal (Theileria) |
| Parvaquone | 4042-30-2 | Antiprotozoal (Theileria). |
| Clorsulon | 60200-06-8 | Anthelmintic (Trematodes) |
| Halofuginone Hydrobromide | 64924-67-0 | Antiprotozoal (coccidiostat) |
| Product | CAS No. | Used In |
|---|---|---|
| Cebrazolone | 17518-98-8 | For Halofuginone Synthesis |
| 3-(Trichlorovinyl) Aniline | 81972-27-2 | For Synthesis of Clorsulon |
| trans-1-(3-Methoxy-2-piperidinyl)-2-typropanone hbr | 64543-93-7 | For Halofuginine HBr Synthesis (side chain) |
| 2-(4-tert butylcyclohexyl) acetic acid | 28125-18-0 | For Buparvaquone synthesis (side chain) |
| 2-(4-tert butylcyclohexyl) acetaldehyde | 88166-21-6 | For Buparvaquone synthesis |
Few Niche APIs are under pilot validation for in specialized therapeutic categories: Antispasmodics, Anticholinergics, and ADHD treatments.
Note: Products covered by valid patents are being developed under experimental aims, exclusively directed to obtain market authorizations of our customers’ generic medicines. Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a patent infringement.